Cipher Pharmaceuticals, Inc. (CPH.TO)
13.65
0.00 (0.00%)
CAD |
TSX |
Oct 09, 16:00
Cipher Pharmaceuticals Profit Margin (Quarterly) : 33.26% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.26% |
| March 31, 2026 | 49.28% |
| December 31, 2025 | |
| September 30, 2025 | 42.87% |
| June 30, 2025 | 44.04% |
| March 31, 2025 | 21.83% |
| December 31, 2024 | 28.29% |
| September 30, 2024 | 2.73% |
| June 30, 2024 | 56.47% |
| March 31, 2024 | 83.91% |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | 58.07% |
| March 31, 2023 | 53.75% |
| December 31, 2022 | |
| September 30, 2022 | 55.38% |
| June 30, 2022 | 38.72% |
| March 31, 2022 | 39.68% |
| December 31, 2021 | 48.04% |
| September 30, 2021 | 17.63% |
| June 30, 2021 | 45.94% |
| March 31, 2021 | 24.58% |
| December 31, 2020 | -1.63% |
| September 30, 2020 | 33.05% |
| June 30, 2020 | 8.73% |
| Date | Value |
|---|---|
| March 31, 2020 | 41.98% |
| December 31, 2019 | 44.79% |
| September 30, 2019 | -37.60% |
| June 30, 2019 | 24.28% |
| March 31, 2019 | 15.87% |
| December 31, 2018 | -7.84% |
| September 30, 2018 | 15.29% |
| June 30, 2018 | 27.53% |
| March 31, 2018 | -20.80% |
| December 31, 2017 | 32.36% |
| September 30, 2017 | 38.72% |
| June 30, 2017 | 44.62% |
| March 31, 2017 | -19.65% |
| December 31, 2016 | -0.30% |
| September 30, 2016 | 28.45% |
| June 30, 2016 | 2.74% |
| March 31, 2016 | 25.87% |
| December 31, 2015 | 21.00% |
| September 30, 2015 | -26.19% |
| June 30, 2015 | -6.32% |
| March 31, 2015 | 33.83% |
| December 31, 2014 | 42.83% |
| September 30, 2014 | |
| June 30, 2014 | 51.57% |
| March 31, 2014 | 49.07% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | -6.95% |
| Bausch Health Cos., Inc. | 9.12% |
| BioSyent, Inc. | 14.34% |
| Revive Therapeutics Ltd. | -- |
| Knight Therapeutics, Inc. | -2.33% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 23.32% |
| Return on Assets | 18.86% |
| Return on Invested Capital | 21.75% |
| Gross Profit Margin (Quarterly) | 65.58% |
| Operating Margin (Quarterly) | 37.08% |
| Return on Net Operating Assets | 26.59% |